InvestorsHub Logo

WeeZuhl

11/20/23 10:22 AM

#391424 RE: mrwrn2010 #391402

40-50+ million annually in revenues and growing, profitable, sales and marketing, and several larger ANDAs than Adderrall in multiple stages of the pipeline, on verge of a 2nd facility for packaging and storage...



And like I said, virtually all of that income is from Adderall. I am happy to see OxyContin submitted and received this year after seven years since pivotal bioequivalence. I am looking forward to another CNS drug application in near future, hopefully two. We've been waiting a long time for those drugs. I am happy for facility upgrades and building ownership and the very best storage facility in all of Northvale. But, we have one single product line that puts all the food on the table, and he owns half. To anyone outside the fanboy club, it looks bad, it smells bad, and it is a barrier to acquisition.

.